Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-GBM autoantibodies specific for α345NC1 hexamers

Identifieur interne : 001093 ( Ncbi/Curation ); précédent : 001092; suivant : 001094

Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-GBM autoantibodies specific for α345NC1 hexamers

Auteurs : Florina Olaru [États-Unis] ; Xu-Ping Wang [États-Unis] ; Wentian Luo [États-Unis] ; Linna Ge [États-Unis] ; Jeffrey H. Miner [États-Unis] ; Sandra Kleinau [Suède] ; Xochiquetzal J. Geiger [États-Unis] ; Andrew Wasiluk [États-Unis] ; Laurence Heidet [France] ; A. Richard Kitching [Australie] ; Dorin-Bogdan Borza [États-Unis]

Source :

RBID : PMC:3563930

Abstract

Goodpasture disease is an autoimmune kidney disease mediated by autoAbs against NC1 monomers of α3(IV) collagen that bind to the glomerular basement membrane (GBM), usually causing rapidly progressive glomerulonephritis. We identified a novel type of human IgG4-restricted anti-GBM autoAbs associated with mild non-progressive glomerulonephritis, which specifically targeted α345NC1 hexamers but not α3NC1 monomers. The mechanisms eliciting these anti-GBM autoAbs were investigated in mouse models recapitulating this phenotype. Wild type and FcγRIIB−/− mice immunized with autologous murine GBM NC1 hexamers produced mouse IgG1-restricted autoAbs specific for α345NC1 hexamers, which bound to the GBM in vivo but did not cause glomerulonephritis. In these mice, intact collagen IV from murine GBM was not immunogenic. However, in Col4a3−/− Alport mice, both intact collagen IV and NC1 hexamers from murine GBM elicited IgG antibodies specific for α3α4α5NC1 hexamers, which were not subclass restricted. As heterologous antigen in COL4A3-humanized mice, murine GBM NC1 hexamers elicited mouse IgG1, IgG2a and IgG2b autoAbs specific for α345NC1 hexamers and induced anti-GBM Ab glomerulonephritis. These findings indicate that tolerance toward autologous intact α3α4α5(IV) collagen is established in hosts expressing this antigen, even though autoreactive B cells specific for α345NC1 hexamers are not purged from their repertoire. Proteolysis selectively breaches this tolerance by generating autoimmunogenic α3α4α5NC1 hexamers. This provides a mechanism eliciting autoAbs specific for α345NC1 hexamers, which are restricted to non-inflammatory IgG subclasses and non-nephritogenic. In Alport syndrome, lack of tolerance toward α3α4α5(IV) collagen promotes production of alloantibodies to α345NC1 hexamers, including pro-inflammatory IgG subclasses which mediate post-transplant anti-GBM nephritis.


Url:
DOI: 10.4049/jimmunol.1202204
PubMed: 23303673
PubMed Central: 3563930

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:3563930

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-GBM autoantibodies specific for α345NC1 hexamers</title>
<author>
<name sortKey="Olaru, Florina" sort="Olaru, Florina" uniqKey="Olaru F" first="Florina" last="Olaru">Florina Olaru</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wang, Xu Ping" sort="Wang, Xu Ping" uniqKey="Wang X" first="Xu-Ping" last="Wang">Xu-Ping Wang</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Luo, Wentian" sort="Luo, Wentian" uniqKey="Luo W" first="Wentian" last="Luo">Wentian Luo</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Ge, Linna" sort="Ge, Linna" uniqKey="Ge L" first="Linna" last="Ge">Linna Ge</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Miner, Jeffrey H" sort="Miner, Jeffrey H" uniqKey="Miner J" first="Jeffrey H" last="Miner">Jeffrey H. Miner</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Renal Division, Washington University School of Medicine, St Louis, Missouri</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Renal Division, Washington University School of Medicine, St Louis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kleinau, Sandra" sort="Kleinau, Sandra" uniqKey="Kleinau S" first="Sandra" last="Kleinau">Sandra Kleinau</name>
<affiliation wicri:level="4">
<nlm:aff id="A4">Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden</nlm:aff>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Cell and Molecular Biology, Uppsala University, Uppsala</wicri:regionArea>
<orgName type="university">Université d'Uppsala</orgName>
<placeName>
<settlement type="city">Uppsala</settlement>
<region nuts="1">Svealand</region>
<region nuts="1">East Middle Sweden</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Geiger, Xochiquetzal J" sort="Geiger, Xochiquetzal J" uniqKey="Geiger X" first="Xochiquetzal J." last="Geiger">Xochiquetzal J. Geiger</name>
<affiliation wicri:level="2">
<nlm:aff id="A5">Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida 32224</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Floride</region>
</placeName>
<wicri:cityArea>Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wasiluk, Andrew" sort="Wasiluk, Andrew" uniqKey="Wasiluk A" first="Andrew" last="Wasiluk">Andrew Wasiluk</name>
<affiliation wicri:level="2">
<nlm:aff id="A6">Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida 32224</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Floride</region>
</placeName>
<wicri:cityArea>Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Heidet, Laurence" sort="Heidet, Laurence" uniqKey="Heidet L" first="Laurence" last="Heidet">Laurence Heidet</name>
<affiliation wicri:level="3">
<nlm:aff id="A7">Service de Néphrologie Pédiatrique, Hôpital Necker-Enfants Malades, Paris, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Néphrologie Pédiatrique, Hôpital Necker-Enfants Malades, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kitching, A Richard" sort="Kitching, A Richard" uniqKey="Kitching A" first="A. Richard" last="Kitching">A. Richard Kitching</name>
<affiliation wicri:level="1">
<nlm:aff id="A8">Department of Medicine, Monash University, Clayton, Australia</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, Monash University, Clayton</wicri:regionArea>
<wicri:noRegion>Clayton</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Borza, Dorin Bogdan" sort="Borza, Dorin Bogdan" uniqKey="Borza D" first="Dorin-Bogdan" last="Borza">Dorin-Bogdan Borza</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<nlm:aff id="A2">Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">23303673</idno>
<idno type="pmc">3563930</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563930</idno>
<idno type="RBID">PMC:3563930</idno>
<idno type="doi">10.4049/jimmunol.1202204</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">001F23</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001F23</idno>
<idno type="wicri:Area/Pmc/Curation">001D79</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001D79</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001932</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001932</idno>
<idno type="wicri:Area/Ncbi/Merge">001093</idno>
<idno type="wicri:Area/Ncbi/Curation">001093</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-GBM autoantibodies specific for α345NC1 hexamers</title>
<author>
<name sortKey="Olaru, Florina" sort="Olaru, Florina" uniqKey="Olaru F" first="Florina" last="Olaru">Florina Olaru</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wang, Xu Ping" sort="Wang, Xu Ping" uniqKey="Wang X" first="Xu-Ping" last="Wang">Xu-Ping Wang</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Luo, Wentian" sort="Luo, Wentian" uniqKey="Luo W" first="Wentian" last="Luo">Wentian Luo</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Ge, Linna" sort="Ge, Linna" uniqKey="Ge L" first="Linna" last="Ge">Linna Ge</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Miner, Jeffrey H" sort="Miner, Jeffrey H" uniqKey="Miner J" first="Jeffrey H" last="Miner">Jeffrey H. Miner</name>
<affiliation wicri:level="2">
<nlm:aff id="A3">Renal Division, Washington University School of Medicine, St Louis, Missouri</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Missouri (État)</region>
</placeName>
<wicri:cityArea>Renal Division, Washington University School of Medicine, St Louis</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Kleinau, Sandra" sort="Kleinau, Sandra" uniqKey="Kleinau S" first="Sandra" last="Kleinau">Sandra Kleinau</name>
<affiliation wicri:level="4">
<nlm:aff id="A4">Department of Cell and Molecular Biology, Uppsala University, Uppsala, Sweden</nlm:aff>
<country xml:lang="fr">Suède</country>
<wicri:regionArea>Department of Cell and Molecular Biology, Uppsala University, Uppsala</wicri:regionArea>
<orgName type="university">Université d'Uppsala</orgName>
<placeName>
<settlement type="city">Uppsala</settlement>
<region nuts="1">Svealand</region>
<region nuts="1">East Middle Sweden</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Geiger, Xochiquetzal J" sort="Geiger, Xochiquetzal J" uniqKey="Geiger X" first="Xochiquetzal J." last="Geiger">Xochiquetzal J. Geiger</name>
<affiliation wicri:level="2">
<nlm:aff id="A5">Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida 32224</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Floride</region>
</placeName>
<wicri:cityArea>Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wasiluk, Andrew" sort="Wasiluk, Andrew" uniqKey="Wasiluk A" first="Andrew" last="Wasiluk">Andrew Wasiluk</name>
<affiliation wicri:level="2">
<nlm:aff id="A6">Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida 32224</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Floride</region>
</placeName>
<wicri:cityArea>Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Heidet, Laurence" sort="Heidet, Laurence" uniqKey="Heidet L" first="Laurence" last="Heidet">Laurence Heidet</name>
<affiliation wicri:level="3">
<nlm:aff id="A7">Service de Néphrologie Pédiatrique, Hôpital Necker-Enfants Malades, Paris, France</nlm:aff>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de Néphrologie Pédiatrique, Hôpital Necker-Enfants Malades, Paris</wicri:regionArea>
<placeName>
<region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kitching, A Richard" sort="Kitching, A Richard" uniqKey="Kitching A" first="A. Richard" last="Kitching">A. Richard Kitching</name>
<affiliation wicri:level="1">
<nlm:aff id="A8">Department of Medicine, Monash University, Clayton, Australia</nlm:aff>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Department of Medicine, Monash University, Clayton</wicri:regionArea>
<wicri:noRegion>Clayton</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Borza, Dorin Bogdan" sort="Borza, Dorin Bogdan" uniqKey="Borza D" first="Dorin-Bogdan" last="Borza">Dorin-Bogdan Borza</name>
<affiliation wicri:level="2">
<nlm:aff id="A1">Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Medicine (Division of Nephrology), Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
<affiliation wicri:level="2">
<nlm:aff id="A2">Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Tennessee</region>
</placeName>
<wicri:cityArea>Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of immunology (Baltimore, Md. : 1950)</title>
<idno type="ISSN">0022-1767</idno>
<idno type="eISSN">1550-6606</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="P1">Goodpasture disease is an autoimmune kidney disease mediated by autoAbs against NC1 monomers of α3(IV) collagen that bind to the glomerular basement membrane (GBM), usually causing rapidly progressive glomerulonephritis. We identified a novel type of human IgG4-restricted anti-GBM autoAbs associated with mild non-progressive glomerulonephritis, which specifically targeted α345NC1 hexamers but not α3NC1 monomers. The mechanisms eliciting these anti-GBM autoAbs were investigated in mouse models recapitulating this phenotype. Wild type and FcγRIIB−/− mice immunized with autologous murine GBM NC1 hexamers produced mouse IgG1-restricted autoAbs specific for α345NC1 hexamers, which bound to the GBM in vivo but did not cause glomerulonephritis. In these mice, intact collagen IV from murine GBM was not immunogenic. However, in Col4a3−/− Alport mice, both intact collagen IV and NC1 hexamers from murine GBM elicited IgG antibodies specific for α3α4α5NC1 hexamers, which were not subclass restricted. As heterologous antigen in COL4A3-humanized mice, murine GBM NC1 hexamers elicited mouse IgG1, IgG2a and IgG2b autoAbs specific for α345NC1 hexamers and induced anti-GBM Ab glomerulonephritis. These findings indicate that tolerance toward autologous intact α3α4α5(IV) collagen is established in hosts expressing this antigen, even though autoreactive B cells specific for α345NC1 hexamers are not purged from their repertoire. Proteolysis selectively breaches this tolerance by generating autoimmunogenic α3α4α5NC1 hexamers. This provides a mechanism eliciting autoAbs specific for α345NC1 hexamers, which are restricted to non-inflammatory IgG subclasses and non-nephritogenic. In Alport syndrome, lack of tolerance toward α3α4α5(IV) collagen promotes production of alloantibodies to α345NC1 hexamers, including pro-inflammatory IgG subclasses which mediate post-transplant anti-GBM nephritis.</p>
</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001093 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 001093 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:3563930
   |texte=   Proteolysis breaks tolerance toward intact α345(IV) collagen, eliciting novel anti-GBM autoantibodies specific for α345NC1 hexamers
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i   -Sk "pubmed:23303673" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024